Nuzenio

Tipranks Innate Pharma

Tipranks Innate Pharma entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Buy Rating Reiterated on Sobi as Diversified Pipeline and Lacutamab Partnership Support Upside; 12‑Month SEK575 Price Target Unchanged - TipRanksTipRanks · Mon, 10 Aug 2026 16:38:51 GMTInnate Pharma price target raised to $7 from $5 at H.C. Wainwright - TipRanksTipRanks · Mon, 10 Aug 2026 16:32:50 GMTInnate Pharma Secures Funding and Advances Lacutamab to Phase 3 With New CMO - TipRanksTipRanks · Mon, 10 Aug 2026 07:56:43 GMTSobi partners with Innate Pharma in $580m lacutamab deal to expand rare cancer portfolio - TipRanksTipRanks · Mon, 10 Aug 2026 06:42:09 GMTInnate Pharma (IDDA) Q4 2023 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sun, 02 Aug 2026 12:57:10 GMTInnate Pharma SA (IDD) Q2 2024 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 01 Aug 2026 11:57:43 GMTInnate Pharma SA (IPHYF) Q2 2024 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Fri, 31 Jul 2026 06:01:15 GMT

Timeline

Mon, 10 Aug 2026 16:38:51 GMTBuy Rating Reiterated on Sobi as Diversified Pipeline and Lacutamab Partnership Support Upside; 12‑Month SEK575 Price Target Unchanged - TipRanks
Mon, 10 Aug 2026 16:32:50 GMTInnate Pharma price target raised to $7 from $5 at H.C. Wainwright - TipRanks
Mon, 10 Aug 2026 07:56:43 GMTInnate Pharma Secures Funding and Advances Lacutamab to Phase 3 With New CMO - TipRanks
Mon, 10 Aug 2026 06:42:09 GMTSobi partners with Innate Pharma in $580m lacutamab deal to expand rare cancer portfolio - TipRanks
Sun, 02 Aug 2026 12:57:10 GMTInnate Pharma (IDDA) Q4 2023 Earnings Report - Results, Call & Slides - TipRanks
Sat, 01 Aug 2026 11:57:43 GMTInnate Pharma SA (IDD) Q2 2024 Earnings Report - Results, Call & Slides - TipRanks

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tipranks Innate Pharma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.